Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Ozyılkan · SciRah

Researcher profile · Semantic Scholar

O. Ozyılkan

Share profile

O. Ozyılkan — researcher profile on SciRah

h-index: 16
Works: 159
Citations: 1,086

Most-cited papers

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
T. Bachelot, E. Ciruelos, A. Schneeweiss, F. Puglisi +288 more
2019Annals of Oncology108 citations Open access
Semantic Scholar
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer.
E. Hamilton, J. Cortés, O. Ozyılkan, Shin-Cheh Chen +11 more
2020Clinical Breast Cancer39 citations
Semantic Scholar
Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.
U. Disel, S. Oztuzcu, A. Besen, C. Karadeniz +6 more
2011Lung Cancer36 citations
Semantic Scholar
Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy
E. Topkan, H. Mertsoylu, Y. Ozdemir, A. Sezer +4 more
2019Cancer Management and Research32 citations Open access
Semantic Scholar
The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
Z. Calikusu, Y. Yıldırım, Zafer Akçalı, H. Sakallı +3 more
2009Journal of experimental & clinical cancer research : CR28 citations Open access
Semantic Scholar
Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience.
F. Kose, A. Besen, Taner Sumbul, A. Sezer +4 more
2011Asian Pacific Journal of Cancer Prevention26 citations
Semantic Scholar
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancer
E. Hamilton, J. Cortés, O. Ozyılkan, Shin-Cheh Chen +8 more
2022Breast Cancer Research and Treatment21 citations Open access
Semantic Scholar
Abstract CT178: Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD): Initial results of the phase 2 KEYLYNK-007 study
M. Maio, R. Shapira-Frommer, T. Yap, T. Ciuleanu +15 more
2021Clinical Trials16 citations
Semantic Scholar
Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis
E. Topkan, U. Selek, A. Kucuk, V. Haksoyler +7 more
2021Journal of Oncology16 citations Open access
Semantic Scholar
Procalcitonin as a biomarker for infection-related mortality in cancer patients.
A. M. Sedef, F. Kose, H. Mertsoylu, O. Ozyılkan
2015Current Opinion in Supportive and Palliative Care15 citations
Semantic Scholar
Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey.
H. Mertsoylu, S. Muallaoğlu, A. Besen, S. Erdoğdu +5 more
2014Asian Pacific Journal of Cancer Prevention14 citations Open access
Semantic Scholar
Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
S. Muallaoglu, U. Disel, H. Mertsoylu, A. Besen +4 more
2013Journal of B.U.ON. : official journal of the Balkan Union of Oncology14 citations
Semantic Scholar
Efficacy and safety results by age in monarchE: Adjuvant abemaciclib combined with endocrine therapy (ET) in patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC).
E. Hamilton, J. Kim, Natalja Eigėlienė, D. Mavroudis +12 more
2023Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
K. Shitara, T. Doi, H. Hosaka, P. Thuss-Patience +12 more
2022Gastric Cancer13 citations Open access
Semantic Scholar
Perspectives and practical applications of medical oncologists on defensive medicine (SYSIPHUS study): a study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
O. Tanriverdi, F. Cay-Senler, T. Yavuzşen, S. Turhal +4 more
2015Medical Oncology11 citations
Semantic Scholar
The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
S. Muallaoğlu, C. Karadeniz, H. Mertsoylu, Ali Ayberk Besen +4 more
2014Journal of B.U.ON. : official journal of the Balkan Union of Oncology11 citations
Semantic Scholar
Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate
F. Kose, H. Abali, A. Sezer, H. Mertsoylu +2 more
2009Leukemia and Lymphoma10 citations
Semantic Scholar
Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience
A. Acibuca, A. Sezer, Mustafa Yilmaz, A. Sumbul +3 more
2021Journal of International Medical Research9 citations Open access
Semantic Scholar
Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study.
U. Akarca, B. Unsal, O. Sezgin, K. Yalçin +15 more
2021The Turkish Journal of Gastroenterology9 citations Open access
Semantic Scholar
Breast cancer in octogenarian women: clinical characteristics and outcome.
T. Y. Kuzan, Emre Koca, O. Dizdar, Ç. Arslan +10 more
2013Journal of B.U.ON. : official journal of the Balkan Union of Oncology8 citations
Semantic Scholar
Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ≥65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.
K. Shitara, T. Doi, H. Hosaka, P. Thuss-Patience +15 more
2019Journal of Clinical Oncology7 citations
Semantic Scholar
Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy.
E. Topkan, U. Selek, Y. Ozdemir, B. Yıldırım +5 more
2018International Journal of Radiation Oncology, Biology, Physics7 citations
Semantic Scholar
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
E. Oktay, M. Levent, Hakan Gelincik, G. Aktaş +26 more
2018Journal of Cancer Education7 citations Open access
Semantic Scholar
The Perspective of Non-oncologist Physicians on Patients with Metastatic Cancer and Palliative Care (ALONE Study): A Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
O. Tanriverdi, T. Yavuzşen, T. Akman, F. Senler +6 more
2015Journal of Cancer Education7 citations Open access
Semantic Scholar
Lack of prognostic significance of C-erbB-2 expression in low- and high- grade astrocytomas.
Saik Muallaoglu, A. Besen, A. Ata, H. Mertsoylu +3 more
2014Asian Pacific Journal of Cancer Prevention7 citations Open access
Semantic Scholar
Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience.
F. Kose, L. Oğuzkurt, A. Besen, Taner Sumbul +5 more
2012European Journal of Radiology7 citations
Semantic Scholar
Signet-ring cell carcinoma of the colon with leptomeningeal involvement.
Y. Yıldırım, Zafer Akçalı, O. Ozyılkan
2010Journal of clinical neuroscience7 citations
Semantic Scholar
Abstract 785: Genomic markers of response to monotherapy abemaciclib in the nextMONARCH 1 study
E. Hamilton, J. Cortés, G. Jerusalem, P. Kaufman +8 more
2020Clinical research6 citations
Semantic Scholar
Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients
E. Topkan, U. Selek, Y. Ozdemir, A. Besen +6 more
2018Journal of Oncology6 citations Open access
Semantic Scholar
Prognostic value of procalcitonin in infection-related mortality of cancer patients.
Ali Murat Sedef, F. Kose, Ahmet Taner Sumbul, O. Dogan +6 more
2016Journal of B.U.ON. : official journal of the Balkan Union of Oncology6 citations
Semantic Scholar
Prognostic significance of the C-erbB-2 expression in turkish non-small cell lung cancer patients.
Z. Calikusu, Y. Yıldırım, Zafer Akçalı, H. Sakallı +2 more
2009Asian Pacific Journal of Cancer Prevention6 citations
Semantic Scholar
273O nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, HER2- metastatic breast cancer
E. Hamilton, J. Cortés, O. Ozyılkan, S.-C. Chen +10 more
20205 citations Open access
Semantic Scholar
Squamous cell carcinoma of the renal pelvis
F. Kose, N. Bal, O. Ozyılkan
2009Medical Oncology5 citations
Semantic Scholar
P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
S. Kılıçkap, U. Demirci, F. Buğdaycı, D. Tural +29 more
2019Journal of Thoracic Oncology4 citations Open access
Semantic Scholar
Unexpected skin lesions after axitinib treatment
A. M. Sedef, F. Kose, Elvan Endoğru Rişvanoğlu, A. Sümbül +3 more
20174 citations Open access
Semantic Scholar
Outcomes of Turkish National Breast Cancer Registry.
S. Kılıçkap, M. Gumus, D. Uncu, M. Ozkan +12 more
20173 citations
Semantic Scholar
Successful Treatment of Aortic Rupture with Endovascular Stent Grafting in a Patient with Mantle Cell Lymphoma
A. Sümbül, F. Kose, L. Oğuzkurt, C. Karadeniz +2 more
2012Case Reports in Oncology3 citations Open access
Semantic Scholar
Erratum to: Rapidly Progressing Malignant Insulinoma Presented with Multiple Liver Metastases: A Case Report
A. Erdogan, F. Kose, H. Akkaya, N. Tutuncu +1 more
2010Journal of Gastrointestinal Cancer3 citations
Semantic Scholar
Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by an Expert Group from Middle East and North Africa Region
H. Azim, O. Ozyılkan, M. Seoud, Amal Ladjeroud +5 more
2022Current Women's Health Reviews2 citations Open access
Semantic Scholar
Clinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study.
Li-Kun Chen, D. Trukhin, O. Kolesnik, Jose David David Gomez Rangel +16 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract PD1-11: nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2- advanced breast cancer
E. Hamilton, J. Cortés, V. Diéras, O. Ozyılkan +9 more
2019Poster Discussion Abstracts2 citations
Semantic Scholar
Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group.
A. M. Sedef, F. Kose, Taner Sumbul, A. Besen +7 more
2019Journal of B.U.ON. : official journal of the Balkan Union of Oncology2 citations
Semantic Scholar
nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2-advanced breast cancer
E. Hamiton, J. Cortés, V. Diéras, O. Ozyılkan +9 more
20192 citations
Semantic Scholar
Lung Cancer: Clinical and Surgical Specifications
A. Balci, Abdurrahman Y. E. Oğur, O. Ozyılkan, A. Turna +33 more
20182 citations Open access
Semantic Scholar
Prognostic and predictive role of FOXP3 positive tumor infiltrating lymphocytes (TILs) in curatively resected non small cell lung cancer other than stage IA
F. Kose, T. Canbolat, A. Fındıkcıoglu, A. M. Sedef +5 more
20172 citations Open access
Semantic Scholar
Acute fatal interstitial lung disease in two cases under treatment of crizotinib
A. M. Sedef, F. Kose, A. Sümbül, A. Sezer +3 more
20162 citations Open access
Semantic Scholar
Thromboembolic Complications of Cancer and Management
Y. Yıldırım, O. Ozyılkan
20092 citations
Semantic Scholar
Outcomes by complete response to first-line pembrolizumab or platinum-based chemotherapy in advanced urothelial carcinoma (UC) in KEYNOTE-361.
O. Ozyılkan, R. Mcdermott, M. J. Juan-Fita, A. Semenov +8 more
2023Journal of Clinical Oncology1 citations
Semantic Scholar
Thoracic Radiotherapy Effect on the Outcome in Extensive Stage Small Cell Lung Cancer.
Ayse Kotek Sedef, B. Yıldırım, A. Sumbul, O. Ozyılkan
2023Journal of the College of Physicians and Surgeons--Pakistan : JCPSP1 citations Open access
Semantic Scholar
Atypical sweet syndrome in the hands of small cell lung cancer patient associated with granulocyte colony-stimulating factor administration
Dogan Ozlem, A. M. Sedef, F. Kose, O. Ozyılkan
2018Journal of Oncological Sciences1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Kose×17
Invite
F. Kose — researcher profile on SciRah
H. Mertsoylu×13
Invite
H. Mertsoylu — researcher profile on SciRah
A. Sezer×11
Invite
A. Sezer — researcher profile on SciRah
A. Besen×8
Invite
A. Besen — researcher profile on SciRah

×7

Invite

A. M. Sedef — researcher profile on SciRah

Invite

I. Çiçin — researcher profile on SciRah

G. Jerusalem×6

Invite

G. Jerusalem — researcher profile on SciRah

Invite

J. Cortés — researcher profile on SciRah

Invite

E. Hamilton — researcher profile on SciRah

Invite

R. Hegg — researcher profile on SciRah

C. Karadeniz×6

Invite

C. Karadeniz — researcher profile on SciRah

K. Petráková×5

Invite

K. Petráková — researcher profile on SciRah